Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
Appointed director
|
|
Statera Biopharma, Inc. (CBLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/25/2022 |
8-K
| Quarterly results |
| 07/28/2021 |
8-K
| Appointed a new director|
Docs:
|
"Certificate of Amendment of Restated Certificate of Incorporation of Cleveland BioLabs, Inc",
"Executive Employment Agreement, as amended, by and among Cytocom Inc. and Michael K. Handley",
"Amendment No. 1 to Executive Employment Agreement, by and among Cytocom Inc. and Michael K. Handley",
"Amendment No. 2 to Executive Employment Agreement, by and among Cytocom Inc. and Michael K. Handley",
"Executive Employment Agreement, as amended, by and among Cytocom Inc. and Taunia Markvicka",
"Amendment No. 1 to Executive Employment Agreement, by and among Cytocom Inc. and Taunia Markvicka",
"Executive Employment Agreement, as amended, by and among Cytocom Inc. and Peter Aronstam",
"Amendment No. 1 to Executive Employment Agreement, by and among Cytocom Inc. and Peter Aronstam",
"Amendment No. 2 to Executive Employment Agreement, by and among Cytocom Inc. and Peter Aronstam",
"Cytocom Inc. Announces Completed Merger with Cleveland BioLabs" |
|
| 05/09/2013 |
8-K
| Quarterly results, Appointed a new director |
|
|